GPD2 and thyroid gland carcinoma: In an animal model of thyroid cancer, mitochondrial glycerophosphate dehydrogenase (mGPDH) was identified as a molecular target for metformin, and downregulation of mGPDH by metformin led to inhibition of thyroid cancer growth in vivo [13].